Albany, NY -- (SBWIRE) -- 10/30/2014 -- According to a new market report published by Transparency Market Research "Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global transfection technology market was valued at USD 386.4 million in 2012 and is estimated to reach a market worth of USD 768.2 million in 2019growing at a CAGR of 9.7% from 2013 to 2019.

Browse Global Transfection Technology Market Report with Full TOC
http://www.transparencymarketresearch.com/transfection-technology.html

Transfection is a technique employed for the introduction of nucleic acids (either DNA or RNA) into cells. This technology helps cells to regulate gene therapy, mutation of cancer cells and protein metabolism by affecting the nuclear genes. There are two types of transfection technologies, stable and transient transfection. While, stable transfection is permanent and the genes are continually expressed even after the host cell replicates, transient transfected genes are expressed for a limited period of time and are not integrated into the host genome.Transfection technology market is driven by the increasing prevalence of cancer and growing obese population, utilization of biopharmaceuticals in the production of proteins and rising prevalence of infectious diseases.

Various government initiatives accentuated the growth of transfection technology market globally. Major factors restraining transfection technology market include high cost associated with transfection technology instruments, cytotoxic effects associated with transfection technology and risk factors during insertion of reagents. It was also observed that companies who were involved in this market collaborated with the local partners to enter emerging markets such as the Asian and African countries. For instance, Life Technologies Corporation acquired KDR Biotech Co., Ltd., a South Korea-based distributor of reagents, in April 2013. This acquisition would further enhance Life Technologies Corporation's revenue in the South Korean biotechnology market.

Based on the method employed, transfection technology market is segmented as reagent-based method, instrument-based method and virus-based method. While certain reagents are utilized as carriers involved in reagent-based transfection, technologicallyadvanced instruments are utilized for instrument-based transfection. The viral gene transfer involves utilization of a virus as a vector for gene delivery which is modified into a replication deficient (unable to replicate). The instrument-based method market is expected to grow at the highest CAGR of 11.0% during the forecast period between 2013 and 2019, owing to its time-saving nature and high accuracy. However, cytotoxic effects associated with instrument-based methods and expensive instruments required for transfection might restrict the growth of the global market. On the other hand, virus-based methods are time-consuming and complicated and the efficiency rate for reagent-based methods is low. These above mentioned factors restrict the growth of the overall transfection technology market.

We can provide sample pages for the better understanding of this report. Request Sample of This Report at:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1001

The global transfection technology market by applications is segmented as biomedical research, therapeutics delivery and protein production. In 2012, bio-medical application of transfection technology covered the major market share of the total transfection technology application market, owing to the rising prevalence of cancer and infectious diseases. Moreover, production of transgenic disease model also accounts for the growth of biomedical research application in the transfection technology market. Transfection technology is widely utilized for the expression of gene and protein studies in various genetic disorders such as Wilson's disease and Fabry's disease. These factors accentuate the growth of the global transfection technology market.

On the basis of geography, the transfection technology market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). In 2012, North America was the largest transfection technology market in the world. North American transfection technology market witnessed significant growth with rising prevalence of various cancers (colon cancer, breast cancer, prostate cancer and cervical cancer). Moreover, government initiatives have also supported the growth of transfection technology market in this region. For example, in February 2012, National Cancer Institute signed a research agreement with Polypus Transfection S.A., a France-based, privately-held company. This agreement states thatPolyethylenimine (PEI) reagent from Polypus Transfection S.A will be utilized by the National Cancer Institute for in-vitro transfection exploration to produce transfected proteins, viruses and antibodies. Europe was the second largest market, and is expected to grow at a CAGR of 8.8% during the study period.

Rising trend of utilization of nano-medicine in diagnostics, targeted drug delivery, clinical trials and drug development studies drives the demand of transfection technology in the European market. The market for transfection technology in Asian countries is at an initial stage. Outsourcing clinical trials to Asian countries by majority of the drug development companies is one of the important factors driving the growth of transfection technology in the Asia-Pacific market. Major market players contributing to the global market for transfection technology are Life Technologies Corporation, Roche Applied Science, PromegaCorporation and Lonza Group Ltd.

The global transfection technology market is segmented as follows:

Transfection Technology Market, by Methods:

- Reagent-based Method
- Lipid mediated transfection (Lipofection)
- Calcium phosphate
- Catonic polymers
- DEAE-dextran
- Activated dendrimers
- Magnetic beads
- Instrument-based Method
- Electroporation
- Biolistic technology
- Microinjection
- Laserfection
- Virus-based Method

Transfection Technology Market, by Applications:

- Bio-medical Research
- Transgenic models
- Cancer Research
- Gene and protein expression studies
- Cell based microarrays for drug discovery and development
- Therapeutic Delivery
- Biotherapeutics
- Electro-chemotherapy and electro-immunotherapy
- Protein Production

Transfection Technology Market, by Geography:

- North America
- Europe
- Asia-Pacific
- Rest of The World

Browse Medical Devices Market Research Reports
http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact :

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: 518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/
Blog: http://tmrresearch.wordpress.com/
Browse Market Research News: http://www.transparencymarketresearch.com/press-releases.htm
Browse Market Research Articles: http://www.transparencymarketresearch.com/articles.htm